TNG462
TNG462-C102
Phase 2 small_molecule active
Quick answer
TNG462 for PDAC is a Phase 2 program (small_molecule) at Revolution Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Revolution Medicines
- Indication
- PDAC
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active